Bøger af Max von Zedtwitz

Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade.

This book analyses the relationships among product safety strategy and culture, concurrent engineering, new product development (NPD) processes and product safety performance.